Wei-Li Shao Sells 4,589 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,589 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $17.24, for a total value of $79,114.36. Following the completion of the sale, the president directly owned 316,238 shares of the company’s stock, valued at approximately $5,451,943.12. The trade was a 1.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The shares were sold at an average price of $12.71, for a total value of $35,956.59.

Omada Health Trading Up 0.8%

NASDAQ OMDA opened at $17.25 on Thursday. The company has a market cap of $1.03 billion and a PE ratio of -63.89. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The stock has a 50 day moving average of $15.63 and a 200-day moving average of $14.79.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million during the quarter. As a group, sell-side analysts predict that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Analyst Ratings Changes

OMDA has been the subject of several research reports. Wells Fargo & Company raised their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Omada Health in a research report on Thursday, June 4th. Needham & Company LLC reiterated a “buy” rating and set a $28.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Evercore reiterated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Finally, BMO Capital Markets lowered their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Institutional Trading of Omada Health

Several large investors have recently modified their holdings of the stock. Perceptive Advisors LLC acquired a new stake in shares of Omada Health during the 2nd quarter worth $44,402,000. Millennium Management LLC grew its holdings in shares of Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares in the last quarter. Loomis Sayles & Co. L P grew its holdings in shares of Omada Health by 23.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after purchasing an additional 346,588 shares in the last quarter. Divisadero Street Capital Management LP acquired a new stake in shares of Omada Health during the 3rd quarter worth $30,510,000. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Omada Health during the 4th quarter worth $16,948,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.